| NINETY ONE GSF EMERGING MARKETS EQUITY FUND IX INC USD | RVI EMERGENTES | 52,47% | 93,97% | 54,91% | · |
| BGF EMERGING MARKETS X2 EUR | RVI EMERGENTES | 52,46% | 62,80% | 27,77% | · |
| CANDRIAM SUSTAINABLE EQUITY EMERGING MARKETS I USD CAP | RVI EMERGENTES | 52,45% | 73,01% | 21,73% | · |
| JPM ASIA PACIFIC EQUITY I (ACC) EUR | RVI ASIA EX-JAPÓN | 52,44% | 90,09% | 63,81% | · |
| JPM ASIA PACIFIC EQUITY I (ACC) USD | RVI ASIA EX-JAPÓN | 52,43% | 89,71% | 63,78% | 232,98% |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | RVI BIOTECNOLOGÍA | 52,39% | 23,89% | -20,33% | · |
| VONTOBEL FUND-MTX EMERGING MARKETS LEADERS G EUR CAP | RVI EMERGENTES | 52,39% | 82,95% | · | · |
| BNP PARIBAS EMERGING EQUITY CLASSIC EUR DIS | RVI EMERGENTES | 52,38% | 72,79% | 26,10% | 48,94% |
| JPM ASIA PACIFIC EQUITY C (ACC) USD | RVI ASIA EX-JAPÓN | 52,38% | 89,48% | 63,46% | 231,68% |
| JPM ASIA PACIFIC EQUITY C (ACC) EUR | RVI ASIA EX-JAPÓN | 52,37% | 89,85% | 63,48% | 231,00% |
